Motus GI reports $19.3M net loss in 2020

Motus GI shared its fourth-quarter and full-year 2020 financial results, posting a $19.3 million net loss for the year, or a $0.60 loss per diluted share.

Here's what you should know:

1. In the fourth quarter of 2020, Motus GI reported a $4.4 million net loss, or a $0.12 loss per diluted share, up from a $5.9 million net loss during the same period in 2019. 

2. The company reported about $20.8 million in cash and cash equivalents as of Dec. 31, 2020. That's a 27.5 percent decrease compared to December 31, 2019. 

3. The company saw fourth-quarter revenue of $36,000, which is a 63 percent decrease from the same period in 2019. 

4. Motus GI attributed sales growth to disposable sleeve sales for its Pure-Vu System. The company also implemented a strategy to pursue reimbursement for the colonoscopy device.

5. Austin-based Dell Seton Medical Center at The University of Texas and New York City-based NYU Langone signed contracts with Motus GI for disposable sleeve purchase orders, effective for 2021.

6. Motus GI CEO Tim Moran said: "We reported a steady increase in commercial momentum during the second half of 2020 compared to the first half of the year. This momentum continued in the fourth quarter despite a resurgence of COVID-19 hospitalizations across much of the United States."

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like